PI

Professor Itescu

Mesoblast Limited | Chief Executive Officer, Executive Director
Dr. Itescu, prior to founding Mesoblast in 2004, Dr. Itescu established an international reputation as a physician scientist in the fields of stem cell biology, autoimmune diseases, organ transplantation, and heart failure. Dr Itescu has been a faculty member of Columbia University in New York, and the University of Melbourne and Monash University in Australia. Itescu has consulted for international pharmaceutical companies, has been an adviser to biotechnology and health care investor groups, and has served on the board of directors of several publicly listed life sciences companies.

Company and Roles

Company
Title
Tenure
Since
MSB
MSB
Mesoblast Limited
  • Chief Executive Officer
  • Executive Director
20yrs, 5mthJun 2004

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
MSB
MSB
Mesoblast Limited
30/06/2467,756,83811,202,09010,653,404N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
MSB
MSB
Mesoblast Limited
10/01/24
Issued
3,693,070$0.285$1,052,524Issue of options
MSB
MSB
Mesoblast Limited
12/12/23
Issued
10,000,000$0.300$3,000,000Rights issue
MSB
MSB
Mesoblast Limited
07/07/23
Issued
2,325,000$1.130$2,627,250Issue of options
MSB
MSB
Mesoblast Limited
25/11/22
Issued
1,550,000$1.010$1,565,500Issue of options
MSB
MSB
Mesoblast Limited
07/07/21
Issued
1,200,000$2.010$2,412,000Issue of options